Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2018 Filed Nov 15, 2018 00:30 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 4,000 | $16.66 | $66,640.00 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 186,000 Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 00:30 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 31,574 | $16.69 | $526,970.06 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,168,426 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 01:46 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 28,505 | $16.73 | $476,888.65 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:27 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 36,493 | $16.76 | $611,622.68 |
DisclosureSEC source: 0001077183-18-000109 · wf-form4_154212283634171.xml · nonDerivative · entry 3 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,391 Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:30 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 100,000 | $16.66 | $1,666,000.00 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,200,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 33,333 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · derivative · entry 6 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 33,333 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · derivative · entry 5 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 39,828 | $17.00 | $677,076.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,505 Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:46 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 35,000 | $4.78 | $167,300.00 |
DisclosureSEC source: 0001077183-18-000115 · wf-form4_154215999703386.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:27 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001077183-18-000109 · wf-form4_154212283634171.xml · derivative · entry 4 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires 2019-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On October 13, 2014, Mr. Shovlin was granted an option to purchase 300,000 shares. The options have time based vesting. On the first anniversary of the option grant date 75,000 shares vest. Then beginning on the thirteenth (13th) month through the fourth anniversary of the option grant date 6,250 shares will vest on a monthly basis. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:27 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 180,000 | $17.05 | $3,069,000.00 |
DisclosureSEC source: 0001077183-18-000109 · wf-form4_154212283634171.xml · nonDerivative · entry 2 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,884 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:27 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 300,000 | $4.79 | $1,437,000.00 |
DisclosureSEC source: 0001077183-18-000109 · wf-form4_154212283634171.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:48 UTC |
Johnson Kevin CDirector
|
SaleCommon Stock | 20,007 | $17.08 | $341,719.56 |
DisclosureSEC source: 0001077183-18-000111 · wf-form4_154212410540118.xml · nonDerivative · entry 2 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,866 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:48 UTC |
Johnson Kevin CDirector
|
SaleCommon Stock | 46,000 | $17.01 | $782,460.00 |
DisclosureSEC source: 0001077183-18-000111 · wf-form4_154212410540118.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,873 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 22:05 UTC |
GENERAL ELECTRIC CO10% owner
|
SaleCommon stock, $0.001 par value per share ("Common Stock") | 4,164,855 | $16.75 | $69,761,321.25 |
DisclosureSEC source: 0000899243-18-028734 · doc4.xml · nonDerivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner GE Medical Systems Information Technologies, Inc. · CIK 0001662667 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,835,145 F1 · ownership.direct: The securities reported herein are owned directly by GE Medical Systems Information Technologies, Inc. ("GE InfoTech"), which is a wholly owned subsidiary of General Electric Company, a New York corporation ("General Electric"). General Electric disclaims beneficial ownership of the Common Stock held by GE InfoTech except to the extent of its pecuniary interest, and the filing of this Form 4 shall not be deemed an admission that General Electric is the beneficial owner of any equity securities of NeoGenomics, Inc. for purposes of Section 16 or any other purpose. F1 · ownership.nature: The securities reported herein are owned directly by GE Medical Systems Information Technologies, Inc. ("GE InfoTech"), which is a wholly owned subsidiary of General Electric Company, a New York corporation ("General Electric"). General Electric disclaims beneficial ownership of the Common Stock held by GE InfoTech except to the extent of its pecuniary interest, and the filing of this Form 4 shall not be deemed an admission that General Electric is the beneficial owner of any equity securities of NeoGenomics, Inc. for purposes of Section 16 or any other purpose. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 22:36 UTC |
BRODIE STEVEN G.VP - Pharma Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,334 | $0.00 Strike: $3.45 | $0.00 |
DisclosureSEC source: 0001077183-18-000095 · wf-form4_154042059835694.xml · derivative · entry 2 BRODIE STEVEN G. · CIK 0001640522 · VP - Pharma Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,334 shares Expires 2019-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 22:36 UTC |
BRODIE STEVEN G.VP - Pharma Operations
|
Exercise / conversionCommon Stock | 13,334 | $3.45 | $46,002.30 |
DisclosureSEC source: 0001077183-18-000095 · wf-form4_154042059835694.xml · nonDerivative · entry 1 BRODIE STEVEN G. · CIK 0001640522 · VP - Pharma Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 20:21 UTC Amendment |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 21,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000071 · wf-form4a_153332765483832.xml · nonDerivative · entry 1 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,008,123 F1 · shares: Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2018 vesting of restricted stock. F2 · balance_after: This Amended Form 4 reflects the corrected presentation of the securities beneficially owned following the withholding of shares to satisfy tax obligations (noted in Footnote 1). This correction is the result of a restricted stock award granted on May 25, 2017 which was inadvertently classified in Table II and was moved to Table I on a Form 4/A filed on August 3, 2018 which amended the Form 4 originally filed on May 30, 2017. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 20:14 UTC Amendment |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GrantCommon Stock | 197,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000069 · wf-form4a_153332725921133.xml · nonDerivative · entry 1 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,030,027 F1 · shares: This Amended Form 4 reflects the corrected presentation of a restricted stock award granted on 5/25/2017; this award was inadvertently classified in Table II and is being moved to Table I. This error also appears in the subsequent Form 4 filed on February 28, 2018. Read SEC document |
| August 01, 2018 Filed Aug 1, 2018 23:56 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 119,948 | $14.00 | $1,679,272.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,300,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 20:27 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GrantCommon Stock | 46,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000073 · wf-form4_153332803778209.xml · nonDerivative · entry 1 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054,552 F1 · shares: On August 1, 2018, Mr. VanOort was granted 46,429 shares of restricted stock. These shares vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 23:56 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 38,952 | $14.00 | $545,328.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,419,948 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 23:56 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 41,100 | $14.01 | $575,811.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,458,900 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 23:56 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 3,500 | $14.00 | $49,000.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 48,657 Read SEC document |
| June 29, 2018 Filed Jun 29, 2018 21:21 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 12,941 | $13.12 | $169,785.92 |
DisclosureSEC source: 0001077183-18-000062 · wf-form4_153030729405818.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,884 F1 · price: Represents the average sales price. Read SEC document |
| June 25, 2018 Filed Jun 26, 2018 21:15 UTC |
GENERAL ELECTRIC CO10% owner
|
OtherSeries A Convertible Preferred Stock · Derivative | 6,864,000 | $7.30 Strike: $7.50 | $50,107,200.00 |
DisclosureSEC source: 0000899243-18-018159 · doc4.xml · derivative · entry 1 GENERAL ELECTRIC CO · CIK 0000040545 · 10% owner GE Medical Systems Information Technologies, Inc. · CIK 0001662667 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2025-12-30 F1 · kind: This Form 4 is being filed in connection with the redemption by NeoGenomics, Inc. ("Issuer") of all of Issuer's outstanding shares of Series A convertible preferred stock, par value $0.001 per share ("Preferred Stock"). F4 · price: The $7.30 per share redemption price was less than the original stated value of $7.50 per share of Preferred Stock. F2 · derivative.exercise_date: The shares of Preferred Stock were exercisable at any time after December 30, 2018, to the extent that the volume weighted average price of Issuer's common stock equaled or exceeded $8.00 per share, as adjusted for standard anti-dilution adjustments, for 30 consecutive trading days. F3 · derivative.underlying_shares: Based on the conversion price and the liquidation preference of the Preferred Stock in effect on the date of this filing, 6,997,467 shares of common stock could have been issued had the Preferred Stock been converted in full on the date of this filing. F5 · ownership.direct: GE Medical Systems Information Technologies, Inc. ("GE InfoTech") is a wholly owned subsidiary of General Electric Company, a New York corporation ("General Electric"). General Electric disclaims beneficial ownership of the securities held by GE InfoTech except to the extent of its pecuniary interest, and the filing of this Form shall not be deemed an admission that General Electric is the beneficial owner of any equity securities of Issuer for purposes of Section 16 or any other purpose. F5 · ownership.nature: GE Medical Systems Information Technologies, Inc. ("GE InfoTech") is a wholly owned subsidiary of General Electric Company, a New York corporation ("General Electric"). General Electric disclaims beneficial ownership of the securities held by GE InfoTech except to the extent of its pecuniary interest, and the filing of this Form shall not be deemed an admission that General Electric is the beneficial owner of any equity securities of Issuer for purposes of Section 16 or any other purpose. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 21:29 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 89,688 | $14.04 | $1,259,219.52 |
DisclosureSEC source: 0001077183-18-000060 · wf-form4_153004855347324.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,500,000 F1 · price: Averages of prices sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 19, 2018 Filed Jun 19, 2018 22:54 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 158,312 | $13.32 | $2,108,066.76 |
DisclosureSEC source: 0001077183-18-000055 · wf-form4_152944885560971.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,589,688 F1 · price: Average of prices sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 22:54 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 2,000 | $13.25 | $26,500.00 |
DisclosureSEC source: 0001077183-18-000055 · wf-form4_152944885560971.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,748,000 F1 · price: Average of prices sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:52 UTC |
Johnson Kevin CDirector
|
GrantCommon Stock · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000048 · wf-form4_152823555885559.xml · derivative · entry 2 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:52 UTC |
Johnson Kevin CDirector
|
GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000048 · wf-form4_152823555885559.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,873 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:50 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000047 · wf-form4_152823543078587.xml · derivative · entry 2 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:50 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000047 · wf-form4_152823543078587.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,346 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:48 UTC |
CROWTHER BRUCE KDirector
|
GrantCommon Stock · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000045 · wf-form4_152823527318260.xml · derivative · entry 2 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:48 UTC |
CROWTHER BRUCE KDirector
|
GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000045 · wf-form4_152823527318260.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,766 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:44 UTC |
HANNAH ALISON L.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000043 · wf-form4_152823502163988.xml · derivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:44 UTC |
HANNAH ALISON L.Director
|
GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000043 · wf-form4_152823502163988.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,013 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:42 UTC |
JONES STEVEN CDirector · Executive Vice President
|
GrantCommon Stock · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000042 · wf-form4_152823489940312.xml · derivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:42 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 230,533 | $12.12 | $2,794,059.96 |
DisclosureSEC source: 0001077183-18-000042 · wf-form4_152823489940312.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,750,000 F1 · price: Average price of shares sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:42 UTC |
JONES STEVEN CDirector · Executive Vice President
|
GrantCommon Stock | 6,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000042 · wf-form4_152823489940312.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,815 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:36 UTC |
HIPP RAYMOND RDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000040 · wf-form4_152823456498053.xml · derivative · entry 2 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:36 UTC |
HIPP RAYMOND RDirector
|
GrantCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000040 · wf-form4_152823456498053.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,580 Read SEC document |
| May 31, 2018 Filed May 31, 2018 21:54 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 17,548 | $11.68 | $204,960.64 |
DisclosureSEC source: 0001077183-18-000036 · wf-form4_152780363232002.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,980,533 F1 · price: Average price of shares sold F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| May 30, 2018 Filed May 31, 2018 21:54 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 37,619 | $11.72 | $440,894.68 |
DisclosureSEC source: 0001077183-18-000036 · wf-form4_152780363232002.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,998,081 F1 · price: Average price of shares sold F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:54 UTC |
JONES STEVEN CDirector · Executive Vice President
|
SaleCommon Stock | 114,300 | $11.67 | $1,333,881.00 |
DisclosureSEC source: 0001077183-18-000036 · wf-form4_152780363232002.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 3,035,700 F1 · price: Average price of shares sold F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · derivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 65,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 35,000 | $11.70 | $409,500.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · nonDerivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,322 F1 · price: Average price of shares sold Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 30,000 | $11.62 | $348,600.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,322 F1 · price: Average price of shares sold Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:50 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 65,000 | $4.78 | $310,700.00 |
DisclosureSEC source: 0001077183-18-000035 · wf-form4_152780340104672.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.